Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing
Recruiting
Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP): Development, Usability, and Acceptability Testing
Who can join
Ages 21 and older · All sexes
Full eligibility criteria
Inclusion Criteria for Participants (Activities 1a, 2a, 3a): * Age ≥ 21 years * Current or previous diagnosis of advanced cancer * Current or previous experience with cancer pain Exclusion Criteria for Participants (Activities 1a, 2a, 3a): * Inability to understand, speak, or read English * Any condition that would impede the patient's ability to complete study procedures such as visual impairment or significant cognitive impairment as determined by the participant's treating provider.
About the study
The purpose of the study is to evaluate if the smartphone app, I-STAMP (Integrated Smartphone Technology to Alleviate Malignant Pain), helps participants with cancer pain manage symptoms and keep track of medications.
What is being tested
- I-STAMP (behavioral)
Sponsor: Dana-Farber Cancer Institute · Participants: 73 · Started: Sep 18, 2026
Contact the study team
- Andrea Enzinger, MD · Phone: 617-582-7335
Official record on ClinicalTrials.gov — NCT06117709
Locations in the U.S.
| Massachusetts | Dana Farber Cancer Institute, Boston |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.